PFDeNA

Developer of artificial intelligence based cancer detection platform.

PFDeNA is a business in deeptech based in Japan.

Profile

PFDeNA is offering artificial intelligence based cancer detection platform. The platform determines the presence or absence of cancer, based on the amount of gene expression of ExRNA present in blood using deep learning technology. The ExRNA or miRNA (microRNA) contribute to the regulation of various biological activities and are applied as diagnostic biomarkers. It is a joint venture of DeNA and Preferred Networks

The company sits in the deeptech segment, where it competes on its core product or service.

Its base of operations is Japan.

The company is listed at the Plug and Play portfolio startup stage of development.

Website: pfdena.com